Will immune checkpoint inhibitors become the new standard of care for urothelial cancer?
The JAVELIN 100 study: a trial to improve lung cancer treatment
Adhering to guidelines can lower the risk of cancer recurrence
Erin Van Blarigan
Exploring the link between chemotherapy-induced toxicities
Lung cancer immuno-oncology clinical trial combinations: inhibiting IDO